These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26968844)

  • 21. Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study.
    Park W; Yoo DH; Jaworski J; Brzezicki J; Gnylorybov A; Kadinov V; Sariego IG; Abud-Mendoza C; Escalante WJ; Kang SW; Andersone D; Blanco F; Hong SS; Lee SH; Braun J
    Arthritis Res Ther; 2016 Jan; 18():25. PubMed ID: 26795209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
    Brandt J; Listing J; Haibel H; Sörensen H; Schwebig A; Rudwaleit M; Sieper J; Braun J
    Rheumatology (Oxford); 2005 Mar; 44(3):342-8. PubMed ID: 15561737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies.
    Wei JC; Baeten D; Sieper J; Deodhar A; Bhosekar V; Martin R; Porter B
    Int J Rheum Dis; 2017 May; 20(5):589-596. PubMed ID: 28544533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Health Outcomes with Etanercept Treatment in Patients with Early Nonradiographic Axial Spondyloarthritis.
    Dougados M; Tsai WC; Saaibi DL; Bonin R; Bukowski J; Pedersen R; Vlahos B; Kotak S
    J Rheumatol; 2015 Oct; 42(10):1835-41. PubMed ID: 26276968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
    Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J
    Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis.
    Martín-Mola E; Sieper J; Leirisalo-Repo M; Dijkmans BA; Vlahos B; Pedersen R; Koenig AS; Freundlich B
    Clin Exp Rheumatol; 2010; 28(2):238-45. PubMed ID: 20483046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    Gorman JD; Sack KE; Davis JC
    N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial.
    Bao C; Huang F; Khan MA; Fei K; Wu Z; Han C; Hsia EC
    Rheumatology (Oxford); 2014 Sep; 53(9):1654-63. PubMed ID: 24729398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Etanercept 25 mg Once Weekly as Effective as 50 mg at Maintaining Response in Patients with Ankylosing Spondylitis? A Randomized Control Trial.
    Yates M; Hamilton LE; Elender F; Dean L; Doll H; MacGregor AJ; Thomas J; Gaffney K
    J Rheumatol; 2015 Jul; 42(7):1177-85. PubMed ID: 26034151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial.
    Sterry W; Ortonne JP; Kirkham B; Brocq O; Robertson D; Pedersen RD; Estojak J; Molta CT; Freundlich B
    BMJ; 2010 Feb; 340():c147. PubMed ID: 20124563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease-modifying effect of etanercept versus sulphasalazine on spinal mobility in patients with ankylosing spondylitis.
    Hendrix S; Koenig A; Li W; Singh A
    J Int Med Res; 2013 Oct; 41(5):1606-11. PubMed ID: 23975857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical research for curing ankylosing spondylitis through combining etanercept, thalidomide and sulfasalazine.
    Xiao P; Pang C; Zhu X; Wu X
    Pak J Pharm Sci; 2015 Jan; 28(1 Suppl):359-62. PubMed ID: 25631513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rates of serious infections, opportunistic infections, inflammatory bowel disease, and malignancies in subjects receiving etanercept vs. controls from clinical trials in ankylosing spondylitis: a pooled analysis.
    van der Heijde D; Zack D; Wajdula J; Sridharan S; Koenig AS
    Scand J Rheumatol; 2014; 43(1):49-53. PubMed ID: 24182312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs.
    Perrotta FM; Addimanda O; Ramonda R; D'Angelo S; Lubrano E; Marchesoni A; Olivieri I; Punzi L; Salvarani C; Spadaro A
    Reumatismo; 2014 Nov; 66(3):208-14. PubMed ID: 25376955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitis.
    Khanna Sharma S; Kadiyala V; Naidu G; Dhir V
    Int J Rheum Dis; 2018 Jan; 21(1):308-314. PubMed ID: 28737251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between inflammation, nocturnal back pain and fatigue in ankylosing spondylitis and improvements with etanercept therapy.
    Hammoudeh M; Zack DJ; Li W; Stewart VM; Koenig AS
    J Int Med Res; 2013 Aug; 41(4):1150-9. PubMed ID: 23803306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
    van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
    Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfasalazine for the treatment of ankylosing spondylitis: relic or niche medication?
    Ward MM
    Arthritis Rheum; 2011 Jun; 63(6):1472-4. PubMed ID: 21630241
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial.
    Huang F; Gu J; Zhu P; Bao C; Xu J; Xu H; Wu H; Wang G; Shi Q; Andhivarothai N; Anderson J; Pangan AL
    Ann Rheum Dis; 2014 Mar; 73(3):587-94. PubMed ID: 23475983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials.
    Sieper J; Koenig A; Baumgartner S; Wishneski C; Foehl J; Vlahos B; Freundlich B
    Ann Rheum Dis; 2010 Jan; 69(1):226-9. PubMed ID: 19465402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.